The initial application of the company’s RNA platform is against White Spot Virus (WSSV), which causes an annual loss of around $3bn and a 15% reduction in global shrimp production.
/PRNewswire/ ViAqua Therapeutics, a biotechnology company and developer of an orally administered RNA-particle platform to promote and improve animal health.